Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity

被引:51
|
作者
Medana, I
Li, ZX
Flügel, A
Tschopp, J
Wekerle, H
Neumann, H
机构
[1] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[2] Univ Lausanne, Inst Biochim, CH-1066 Epalinges, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 02期
关键词
D O I
10.4049/jimmunol.167.2.674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous work showed that neurons of the CNS are protected against perforin-mediated T cell cytotoxicity, but are susceptible to Fas-mediated apoptosis. In this study, we report that Fas ligand (FasL) expression by neurons is involved in protection against perforin-mediated T cell cytotoxicity. Gene transcripts for FasL were identified in single murine hippocampal neurons by RT-PCR combined with patch clamp electrophysiology, and constitutive expression of FasL protein was confirmed in neurons by immunohistochemistry. Neurons derived from wild-type C57BL/6 (BL6) mice and mutant BL6.gld mice lacking functional FaSL were confronted with allogeneic, CTLs and continuously monitored in real time for changes in levels of intracellular calcium ([Ca2+](i)), an indicator of cytotoxic damage. Perforin-mediated plasma membrane lysis, characterized by rapid, massive [Ca2+](i) influx into the target cells within 0.5 h, was not detected in wild-type neurons. In striking contrast, FasL-deficient neurons showed rapid increase in [Ca2+](i) within 0.5 h, reflecting perforin-dependent cell lysis. FasL seems to protect neurons by blocking degranulation of CTLs, since CD3-induced release of cytotoxic granules was reduced by coapplication of Fas-specific Abs or rFasL.
引用
收藏
页码:674 / 681
页数:8
相关论文
共 50 条
  • [31] Upregulation of Fas/FasL (CD95/CD95L)-mediated epithelial apoptosis: a novel therapeutic target in pouchitis
    Coffey, JC
    Bennett, MW
    Wang, JH
    Neary, P
    O'Connell, J
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    BRITISH JOURNAL OF SURGERY, 2001, 88 (05) : 756 - 756
  • [32] Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back - Commentary
    Walker, PR
    Saas, P
    Dietrich, PY
    JOURNAL OF IMMUNOLOGY, 1997, 158 (10): : 4521 - 4524
  • [33] Resistance to Gemcitabine (OEM) in a Fas-ligand (FasL)-resistant cell line is not dependent on the Fas/Fasl (CD95/CD95L) system
    Meli, M
    Tolomeo, M
    D'Alessandro, N
    Grimaudo, S
    Ruberti, G
    Papoff, G
    Rausa, L
    Dusonchet, L
    ANNALS OF ONCOLOGY, 1998, 9 : 133 - 133
  • [34] Elimination of activated but not resting primary human T cells by Fas Ligand (CD95L)-expressing Killer-DC.
    Hoves, S
    Krause, SW
    Halbritter, D
    Mountz, JD
    Schölmerich, K
    Fleck, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S632 - S632
  • [35] RELATIVE PERFORIN-MEDIATED AND FAS-MEDIATED LYSIS IN T1 AND T2 CD8 EFFECTOR POPULATIONS
    CARTER, LL
    DUTTON, RW
    JOURNAL OF IMMUNOLOGY, 1995, 155 (03): : 1028 - 1031
  • [36] Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis
    Campanelli, AP
    Martins, GA
    Souto, JT
    Pereira, MSF
    Livonesi, MC
    Martinez, R
    Silva, JS
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (09): : 1496 - 1505
  • [37] Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T Lymphocytes by the protooncogene bcl-2
    Schroter, M
    Lowin, B
    Borner, C
    Tschopp, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) : 3509 - 3513
  • [38] Taking out the immune response - The roles of fas-ligand (CD95L) in immune regulation
    Green, DR
    Tietz, B
    Ferguson, TA
    Brunner, T
    PROGRAMMED CELL DEATH, 1997, : 147 - 158
  • [39] Fas ligand (CD95L) induction in human lymphocytes by the apoptosis-inducing mistletoe lectins
    Büssing, A
    Stein, GM
    Vervecken, W
    Pfüller, U
    Schietzel, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S358 - S358
  • [40] Metabolic disruption as a mechanism for inducing susceptiflity to fas (CD95): FasL (CD95L) mediated tumor cell death
    Newell, M. Karen
    Das, Stuti
    Rogers, Susannah Kathleen
    Villalobos-Menuey, Elizabeth
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 : S52 - S53